Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis

Table 1 Clinical characteristics of patients with rheumatoid arthritis (n = 164)

Age	60.4 (12.0)^a
Female, n (%)	140 (85.4)
Disease duration (n = 153)
<1 year, n (%)	23 (15.0)
1–5 years, n (%)	45 (29.4)
>5 years, n (%)	85 (55.6)
DAS-28 (n = 69)	3.3 (1.5)^a
Swollen joint count (n = 137)	1 (0–23)^b
Tender joint count (n = 92)	1 (0–28)^b
Patients' global assessment (VAS) (n = 56)	23.2 (23.5)^a
ESR (mm/first hour) (n = 152)	28.8 (19.3)^a
CRP (mg/l) (n = 160)	13.9 (23.2)^a
IL-6 (pg/ml) (n = 74)	111.0 (292.2)^a

^aMean (standard deviation). ^bMedian (range). CRP, C-reactive protein (normal values 0–6 mg/l); DAS, disease activity score; ESR, erythrocyte sedimentation rate (normal values 0–10 mm/first hour); IL-6, interleukin-6 (normal values 0–3 pg/ml); VAS, visual analogue scale (range 0–100 mm).

ISSN: 1478-6362